Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.7114
+0.01171.67%
Post-market: 0.6972-0.0142-2.00%19:44 EDT
Volume:388.05K
Turnover:271.81K
Market Cap:23.67M
PE:-0.76
High:0.7400
Open:0.7149
Low:0.6545
Close:0.6997
52wk High:2.87
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.39
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:16.75
PE(LYR):-0.18

Loading ...

Jasper Therapeutics Posts Investor Presentation on Kira Merger, PIPE Financing and Immunology Pipeline Strategy

Reuters
·
Jul 17

Jasper Therapeutics Completes Acquisition of Kira Pharmaceuticals in All-stock Deal

Reuters
·
Jul 17

Jasper Therapeutics - Announces $132 Mln Private Placement of Convertible Preferred Stock

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics - Combined Company Operations Expected to be Funded Through Second Half of 2028

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics trading halted, news pending

TIPRANKS
·
Jul 17

NASDAQ Trade Halt Halt News Pending at 05:10 Pm

Reuters
·
Jul 17

Insider Traders Lose US$287k As Jasper Therapeutics Drops

Simply Wall St.
·
Jun 30

Jasper Therapeutics announces annual shareholder meeting

Reuters
·
Jun 16

Jasper Therapeutics - on June 3, 2026, Co Receives Nasdaq Notice for Minimum Bid Price Non-Compliance - SEC Filing

THOMSON REUTERS
·
Jun 10

Jasper Therapeutics gets Nasdaq notice after shares trade below $1 bid-price minimum

Reuters
·
Jun 10

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate

Benzinga
·
Jun 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 02

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant

Reuters
·
Jun 01

Jasper Therapeutics Explores Sale, Merger and Other Strategic Alternatives

MT Newswires Live
·
Jun 01

Jasper Therapeutics explores strategic alternatives, including asset sale or merger, to maximize shareholder value

Reuters
·
Jun 01

Jasper Therapeutics - Options Include Asset Sale, Licensing, Collaborations, Company Sale, Merger, or Wind-Down

THOMSON REUTERS
·
Jun 01

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS
·
Jun 01

Jasper Therapeutics Announces Board Resignation and Committee Change

TIPRANKS
·
May 22